We are very proud that many RIMLS researchers are working on projects related to the COVID-19 virus. Some of these projects have already resulted in important publications that were made available as quickly as possible to help the fight against Corona worldwide.
Please find below some of our publications which appeared timely from the groups of:
Frank van de Veerdonk:
- New insights; Consequences for treatment are now being examined internationally (link) -published in Preprints
Raphaël Duivenvoorden:
-
New insight into the effect of hydroxychloroquine (link) - published in MedRxiv
-
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons (link) - published in Cell Reports Medicine
Johan van der Vlag:
Frank Wagener & Peter Pickers:
-
Important insights into the molecular mechanisms of COVID-19 infections (link) - published in Antioxidants
Alexander Hoischen & Frank van de Veerdonk:

Renal Disorders
- COVID-19 and the kidney: overview of papers
A lot of our research projects are still ongoing and important funders have decided to grant several of the research projects of RIMLS researchers, e.g.:
We wish all our researchers success in their efforts to fight the current COVID-19 pandemic. If you would wish to further support their important work please click here
Related news items
.aspx?width=306&height=184&ext=.png&type=BlockColumn1Zoom1)
Four new professors explain the need for cooperation in developmental neuroscience
27 January 2021In the past, developmental neuroscience was not a field in which people from different disciplines cooperated very much. However, in recent years, the approach has been gradually changing. Four newly appointed professors at Radboudumc/ the Donders Institute understand the importance of teaming up.
read more
Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis
25 January 2021Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.
read more
Oral health research makes significant impact at the 148th WHO Executive Board meeting
25 January 2021During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.
read more
Radboud Young Academy safeguards the future of science
21 January 2021New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.
read more
Increase radio- and immunotherapy efficacy by targeting hypoxia
21 January 2021In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.
read more
Radiation boost lowers risk of prostate cancer recurrence
21 January 2021An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.
read more